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Abstract 
Despite the widespread use of Traditional Medicine (TM) in developing countries, 
many questions surrounding the nature of demand for TM remain unexplored. As one of 
the fundamental dimensions of China’s health care system, Traditional Chinese Medicine 
(TCM) has played a changing role as China’s economy has grown and political leaders have 
promoted TCM, however, very limited research explored the nature of the relative demand 
for TCM and CM to guide the health policy design and health system integration in current 
China.        
To fill in this information gap, this study explored the nature of demand for TCM and 
the associations between wealth and TCM utilization using a nationally representative, 
longitudinal study in China. We described TCM and CM utilizations by demographics, 
chronic conditions and examined how TCM use varies with wealth employing OLS 
regressions. Heterogeneity in the association between wealth and TCM use was also tested. 
The study found that the TCM use prevalence was 28.7% and nearly 91% of the population 
who used TCM also used CM. TCM users were found to be older, female, less educated and 
more likely to have chronic conditions. The regression results revealed a positive 
relationship between wealth and TCM, which suggests that TCM is a normal good. We also 
found a stronger association between wealth and TCM in older population but no 
heterogeneity was found across people with different chronic conditions and education 
levels. In conclusion, our findings suggest that TCM is a normal good with the possibility of 
being demanded as a complement of CM, playing an important role in chronic conditions 
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1. Introduction 
Traditional medicine (TM)1 comprises a major part of health services provided 
worldwide, especially in developing countries where the availability of conventional 
medicine (CM)-based health is relatively limited.1 In many low-income countries, 
particularly in rural areas, TM practitioners serve as the main or sole providers of health 
care services.1 In Chile, Ethiopia, and India, up to 80% of the population relies on TM for 
primary health care needs.1, 2 In some cases, TM is actively promoted by policymakers: The 
World Health Organization (WHO), for instance, has officially promoted the integration of 
TM into conventional health care systems in developing countries as a cost-effective 
approach to address escalating health needs.1 In some countries, such as China and Laos, 
TM is viewed as an important piece of cultural heritage and is officially promoted as an 
effective way to combat human disease.3  
Despite the widespread use of TM in developing countries, many questions 
surrounding the nature of demand for TM remain unexplored. Existing research mainly 
focuses on the historical development and broad trends of TM, whereas limited research 
focuses on micro-level determinants of demand. Independent of the relative efficacy of TM 
compared to CM approaches, understanding how patients choose to use TM is critical to 
inform policies regarding the role of TM in developing country health systems. For 
instance, if TM is used as a substitute for CM, is it an ‘inferior good’ in the sense that 
demand shifts away from TM as wealth increases? On the other hand, is TM a normal good 
                                                      
1 WHO defined Traditional Medicine as “the sum total of the knowledge, skill, and practices based 
on the theories, beliefs, and experiences indigenous to different cultures, whether explicable or not, 
used in the maintenance of health as well as in the prevention, diagnosis, improvement or 
treatment of physical and mental illness.” 
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in the sense that increases in wealth lead to increased demand? Is TM demanded as a 
complement to CM? How does this pattern of TM use changes across age, education and 
type of diseases?  These questions on the nature of demand for TM have important 
implications for the design of health policy, particularly in countries with strong traditions 
of traditional treatment where both TM and CM services are widely available. 
In this paper, we address these questions in the Chinese context given the large role 
TM plays in China. In recent years, the Chinese government has actively promoted 
Traditional Chinese Medicine (TCM) development, integration, and supervision in recent 
years in response to the population aging and enlarged disease burden.4, 5 Even though 
understanding these determinants of TCM utilization is critical to health policy design, 
there is limited evidence on the demand for TM in China and how this related to demand 
for CM. Previous studies show mixed results of patterns of TCM use in China. Studies have 
conflicting views on genders, living areas, and education levels. 5, 6 More importantly, while 
some have hypothesized that use of TM would decrease with increasing wealth in China, 
existing studies show that TM use is still remarkably high despite the robust income 
growth in China during the past two decades. Currently, there is no systematic study 
examining the correlations between wealth and TCM use in China.  
Research Questions 
In light of this gap in the current literature, this study investigates the utilization of 
TCM in relation to CM among older population in China. The primary aims of this study are:  
1) To describe the use of TCM and CM and how it varies with demographics and disease types  
2) To identify how the use of TCM and CM varies with wealth and how this correlation 
changes after controlling for confounding factors  
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3) To examine how this relationship between wealth and TCM use varies by disease type and 
across age and education 
We address these aims by analyzing data from the most recent wave (2015) of the China Health 
and Retirement Longitudinal Study (CHARLS). The CHARLS provides a comprehensive and rich 
dataset on health service utilization that allows us to estimate various determinants of TCM use. 




Traditional Medicine (TM) in Developing Countries 
Traditional medicine (TM) is a medical science that was formed and developed in 
the process of fight against diseases over thousands of years. It is variously known as the 
traditional healer, folk medicine, native healing or complementary medicine in different 
regions.7 However, there is no universal definition of the term since many countries have 
evolved their own forms of TM such as Chinese, Indian and African traditional medicines.7 
Across the world, TM is an important and often underestimated part of health care.8 It is 
currently found in almost every country in the world, and the demand is found to escalate 
in both developed and developing countries.2 In some African countries such as Uganda 
and Ethiopia, the prevalence of traditional healers use for primary care needs is as high as 
90%.9 More importantly, in many developing countries which focus on integrating TM into 
conventional health care systems, political engagement in TM has also increased 
substantially during the past decade.8 Some countries further expand their interests in TM 
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products to focus on TM practices and practitioners including education and research to 
facilitate TM development.8 
Despite differences in culture, regulations and historical significance, three general 
patterns are documented by WHO to explain the persistent utilization of TM worldwide: 
cultural and historical influences, primary sources of health care, and complementary 
therapy.1 While such patterns mostly occurred in western countries, a few studies in some 
developing countries have supported similar patterns.10 Firstly, enduring cultural and 
social factors such as influences from family and friend still contribute to TM use patterns 
even though many expect that the advanced education and increased access to CM would 
lead to a diminishing identify of TM in younger generations. A study conducted in urban 
area suggests that most TM users had received knowledge of traditional herbs from their 
family, and 28% of had obtained the herbs from family or friends.2  Secondly, overall 
increases in health services consumption following escalating noncommunicable diseases 
(NCDs) burden may also be responsible for TM’s high utilization rates in many developing 
countries. WHO estimates that NCDs will lead to 70% of deaths in developing countries.11 
As chronic diseases replace infectious diseases to be the major disease burden in many 
developing countries, it may be expected that TM utilization rates would increase given the 
important role TM plays in chronic disease treatment.12 Thirdly, previous studies indicate 
that the increasing TM use results from a growing trend for patients to take a more 
proactive approach to their own health.13 These patients actively seek out different forms 
of self-care with increased access to health services and awareness of available alternatives 
for treatment.13 It is also possible that demand for health services has increased along with 
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wealth, but CM remains less widely available than TM, leading to increased demand for TM 
services. 
Existing studies in many developing countries have found that income level, 
education, geography, and self-reported health were associated with the use of TM.9, 14  In 
addition to socio-demographic factors, several studies also show that population with 
chronic conditions such as cardiovascular diseases and stroke had a higher TM utilization 
rate, which highlights disease type as another possible determinant of TM use.6, 9  However, 
different studies have conflicting views of the nature of demand for TM. For example, 
historically, the common wisdom in developing countries is that poor and marginalized 
people are highly reliant on TM.13 A study conducted in rural areas confirms this 
assumption, finding that low-income families had a higher utilization rate of TM because 
they have limited access to CM.15 However, another study indicates that poverty was not 
related to the use of TM.2 Therefore, currently there is no consistent answer as to what 
factors contribute to the continued and even increased use of TM in many developing 
countries. WHO believes that TM’s diversity, flexibility, availability and affordability offer 
alternatives for patients who have limited access to CM.1 However, several recent studies 
on TM use show that the majority of the patients are using combined treatments with both 
TM and CM included.7, 14 Currently, there is no systematic study focusing on the relative 
demand for TM and that for CM. 
 
TCM in China 
Traditional Chinese Medicine (TCM) is rooted in the ancient philosophy of Taoism 
with a history of more than 2,500 years in China, encompassing a wealth of different 
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practices.16 Since the People’s Republic was founded in 1949, China has been strengthening 
the role of TCM in its health care system by publishing major guidelines on uniting Chinese 
and conventional medicine.17 Alongside CM, TCM plays an integral role in the Chinese 
culture and health care system, especially in the prevention and treatment of chronic 
diseases.18 In China, there are about 440,700 health-care institutions providing TM 
services, with 520,600 patient beds, including all levels of TM hospitals and general 
hospitals, clinics and health stations in urban and rural areas.1 Even though only a small 
portion of Chinese people prefer TCM to CM treatment when they are sick, TCM has been 
consistently playing an active role in China’s three-tier medical system including hospitals, 
health centers, and clinics.5  
China has established formal TCM hospitals since 1949 to protect TCM as a cultural 
heritage and provide affordable health services.5 Currently, 13.8% of hospitals in China are 
TCM hospitals and 1.3 billion TCM outpatient visits per year account for one-third of the 
total outpatient visits in China. 5 In addition, TCM is practiced alongside CM in both health 
centers and clinics.5 About 75% of health centers have a TCM department, and more than 
30% of the total medicine utilization in health clinics was from TCM, more than that of TCM 
hospitals or health centers.5  
Available studies show that demand has persisted even with the robust income 
growth in China in the past two decades.10 Statistics show that the proportion of patient 
visits to TCM hospitals and doctors increased from 14% of total medical care visits in 2011 
to 16% in 2015.10  Currently, TCM comprises around 40% of all health care services and 
Chinese traditional herb accounts for 30-50% of the total medicine consumption in China, 
playing an indispensable role in the national health care system.19 Several potential factors 
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may contribute to this persistent rate of TCM utilization. An important one may be 
population aging. One study indicated that approximately 20% of middle-aged and older 
adults use TCM in their daily treatments in China.17 This is consistent with other studies 
showing that age is positively associated with people’s choice of TCM treatment, likely 
because older generations are more comfortable using TM.20, 21 The aging population in 
China has also contributed to an epidemiological transition from communicable disorders 
to chronic noncommunicable diseases (NCDs) and the population aged 60 years and over is 
expected to reach 30% by 2030.22, 23 Some previous studies show that people with chronic 
conditions are more likely to use TCM: a study conducted in community health centers 
shows that proportions of those consulting acupuncturists and TCM herbalists for chronic 
conditions were significantly higher than that for acute conditions.24 This pattern is 
consistent with the common perception in China, where people believe that TCM has 
special strength in treating certain chronic conditions.25 With continued population aging 
and increases in chronic diseases, many expect the rate of TCM use to continue to rise.17  
Another possible explanation for persistent TCM use in China is the growing 
economy and increasing wealth and demand for health care. Given the rapid economic 
growth and health insurance expansion in the past two decades, patients in China can 
increasingly afford both TCM and CM. Decades of efforts to address the social disparities in 
national health systems resulted from excessive pursuit of economic performance largely 
increased access to affordable health services in both urban and rural areas.26 As the major 
financer of health services, medical insurance system plays an important role in medication 
use including both TCM and CM, both of which are covered by health insurance schemes in 
China with TCM having a higher insurance compensation ratio.26, 27 In 2011, medical 
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institutions in China hosted 6.27 billion outpatients, as compared with 2.15 billion in 
2002.28 This marked rise in health care utilization could possibly lead to increases in TCM 
use. 
However, the validity of this explanation depends on the interrelationship between 
TCM and CM. If CM and TCM are substitutes, as the demand for CM increases and people 
becomes wealthier, the demand for TCM may decrease. However, if CM and TCM are 
complements, demand for TCM could persist or even grow as people use more CM with 
robust income growth. As the concept of complementarity between TCM and CM is well 
received in the Chinese community, there might be a rising preference for using both TCM 
and CM to enhance clinical improvement, with each modality addressing different aspects 
of the illness.12 TCM is widely used in disease prevention, health promotion and health 
maintenance, as a result of which many people choose to use TCM as a complement to CM 
for chronic disease management. A Chinese hospital study of recorded prescriptions shows 
that as much as 76% of general patients used the combination therapy with both TM and 
CM included.29 This implies the possibility of TCM being demanded as a complement to CM 
instead of a low-cost substitute. However, more comprehensive research is needed to 
investigate the relationship between TCM and CM use in China. 
 The nature of demand for TCM has important implications for China’s ongoing 
health reforms. As the Chinese government is devoted to promoting the integration of TCM 
into conventional health care system, what role TCM plays in relation to CM in the current 
health care system provides valuable information on health resources allocation and future 
policy design. In response to barriers of this system integration, China is undergoing major 
health reforms in order to improve quality and safety of TCM. For example, the recently 
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issued ‘White Paper’ reinforced the TCM’s distinct strengths including its clinical 
effectiveness, its flexible ways of treatment, and relative low cost in disease prevention and 
health care and emphasized the importance of professional TCM education and licensing to 
further protect and expand the role of TCM in the health care system.17 In 2016, the State 
Council established the annual joint session to make policies for the development of TCM, 
instructing implementation, and solving potential problems.30 As policymakers in China 
claimed that TCM has been proved effective in disease treatment and is very popular 
among the Chinese public for its low cost, they wish to fully exploit TCM’s distinct 
characteristics to augment benefits of reform for the people as WHO recognizes that TCM 
integration is cost-effective.1, 17 All of these recent efforts aimed to expedite development of 
TCM disease prevention and health care services to provide accessible, affordable, and safe 
health services. The endpoint of this study is to help better inform health policy 
development and decision-making in China. 
 
3. Methods 
Data source and participants 
This study conducted a secondary data analysis using the CHARLS, a nationally 
representative longitudinal survey of the Chinese population aged 45 years or older and 
their spouses.31 It is based on the Health and Retirement Study (HRS) and related aging 
surveys such as the English Longitudinal Study of Aging (ELSA) and the Survey of Health, 
Aging and Retirement in Europe (SHARE).31 In response to the rapid ageing of the 
population in China, the CHARLS set up a high-quality public micro-database, which 
includes assessments of social, economic, and health circumstances of community 
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residents.31 Core CHARLS questionnaires include information on demographics, family 
structure and changes, health status and functioning, chronic illnesses, health care and 
insurance, and income and assets.31  
The CHARLS is conducted every two years with more than 17,000 participants.31 
Participants were selected using a four-staged, stratified, cluster sampling method.32 The 
survey covered 28 provinces, 150 countries/districts, and 450 villages/urban communities 
in China.33 All samples were approached for in-person interviews in their homes with the 
use of CAPI technology by trained interviewers.31 The interviewers also carried equipment 
for and conducted measurements of health functioning and performance in respondents’ 
households.31 Ethics approval for the data collection was obtained from the Biomedical 
Ethics Review Committee of Peking University (IRB00001052-11015). All participants 
signed an informed written consent form before the survey. 
Information in CHARLS is based on self-reports. It includes two distinct 
questionnaire instruments: household questionnaire and biomarker survey. This study 
used data from the household questionnaire in 2015 (Wave 4) including information on 
TCM and CM use, current health status (chronic conditions), and socio-demographic status 
such as age, education, hukou type, and household wealth. We specifically used data on 
individuals who were aged 45 or above in 2015 because we are interested in the TCM use 




TCM and CM Utilization: 
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 The dependent variables of interest are TCM and CM use. In this paper, TCM is 
defined as a set of practices including Chinese herb medicine, acupuncture, moxibustion, 
Chinese massage, cupping, and guasha in this study and CM includes all non-TCM 
treatments.4  Measurements of TCM and CM use were based on questionnaire items. The 
survey asks “Are you now taking any of the following treatments to treat or control your 
illness or its complication?” and provides four options, including 1) taking TCM,  2) taking 
CM, 3) other treatments, and 4) none. For this paper, an individual is categorized as using 
TCM if he or she answered 1) taking TCM. The individual is categorized as using CM if he or 
she answered 2) taking CM or 3) other treatments. As all questions related to TCM use as 
mentioned above allow multiple responses, they provide additional information on the 
complementarity of TCM.  
 
Wealth: 
 Although income or consumption are more often used in studies of demand 
elasticities, measuring income and consumption is challenging due to the self-report biases 
in income and consumption measures and lack of data on price and expenditures.34 
Moreover, these measures may be inappropriate for certain populations such as retired 
individuals or rural populations engaged in agriculture, who comprise a large portion of 
the survey sample. In this paper, we instead focused on measuring the elasticity or demand 
with respect to wealth. In the survey, the respondents were asked to assess the value of 
their household possessions, including automobile and motorcycle, TV and computer, and 
valuable decorations and antiques. As there is no standard wealth index provided by the 
CHARLS, we generated a standard wealth index using a principal components analysis 
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(PCA) of information on ownership of household assets to measure household wealth.35 
The PCA approach has been shown to provide an appropriate measure of long-run 
household wealth.34  
 
Other Covariates:  
 The CHARLS survey includes comprehensive information on age, gender, education 
level, hukou type, and household wealth. Core questionnaires also provide information on 
health status and functioning, which includes chronic medical conditions. Respondents 
were asked if they had been diagnosed with any of the following chronic medical 
conditions: hypertension, dyslipidemia, diabetes, cancer, chronic lung, liver, heart, stroke, 
kidney, digestive, psychiatric, memory, arthritis, and asthma. Dichotomous variables for 
chronic medical conditions were created for further analysis. For analysis purposes, the 
study mainly focused on data related to chronic conditions and patient wealth. 
 
Empirical Approach 
To describe the use of TCM and how it varies with different covariates (Objective 1), 
we first summarized the use of TCM by chronic diseases type and socio-demographic 
variables such as age, education, hukou type and household wealth. The descriptive 
statistics of the outcome variables illustrate raw differences between individuals who use 
TCM and those who do not use TCM. In addition, to flexibly estimate the relationship 
between wealth and TCM use, we used non-parametric regression and presented results 
graphically. 
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 Next, to examine how demand for TCM is related to wealth after adjusting for 
observable confounding factors (Objective 2), we employed ordinary least squares (OLS) 
regressions using the variables defined as above. In OLS regression, the estimated equation 
is calculated by determining the equation that minimizes the sum of the squared distances 
between the sample’s data points and the values predicted by the equation. The estimation 
equation is specified as follows: 
TCMi = 𝛼 + 𝛽1 ∙ 𝑊𝑒𝑎𝑙𝑡ℎ𝑖 + 𝑋𝑖
′𝛾 + 𝜀𝑖  
 In this equation, 𝑇𝐶𝑀𝑖 is the outcome measured in 2015 for individual 𝑖;  𝑊𝑒𝑎𝑙𝑡ℎ𝑖  is 
the wealth of individual i; and Xi is a set of observed characteristics of the individual and 
household that may be correlated with both TCM use and wealth; and εi is the error term. 
In evaluating the adjusted relationship between wealth and TCM use, we estimated two 
specifications: one with the continuous wealth index (assuming that the relationship is 
linear) and another with indicators for the index quantiles, which allows for a non-linear 
relationship. To observe how the relationship between wealth and TCM use changes with 
the inclusion of additional controls, we estimated several specifications sequentially adding 
sets of covariates to 𝑋. In all regressions, we controlled for CM use. In the full model, 𝑋 also 
includes demographic variables (i.e. age, gender, education, and hukou type) and area fixed 
effects (province). Area fixed effects were taken into consideration in order to account for 
fixed characteristics at the province level that may affect both TCM use and wealth. 𝛽1 is the 
key coefficient of interest and captures the relationship between wealth and TCM use. In all 
regressions, Huber-White robust standard errors were used to account for possible 
heteroscedasticity.  
 17 
 Finally, to further investigate how the relationship between wealth and TCM use 
varies by chronic conditions and across age and education (Objective 3), we employed OLS 
regressions as applied in Objective 2 but a different model was constructed to examine the 
unobserved heterogeneity of the association between wealth and TCM use across different 
socio-demographic status. The revised estimation equation is specified as follows: 
TCMi = 𝛼 +  𝛽1 ∙ 𝑊𝑖 + 𝛽2 ∙ 𝑊𝑖 ∗ 𝐷𝑖 + 𝛽3 ∙ 𝐷𝑖 + 𝑋𝑖
′𝛾 +  𝜀𝑖 
where Wi is a binary indictor which equals one if the individual wealth score is lower than 
the median. Di is a dummy variable for one of our variables of interest including age, 
education, and chronic conditions. The interaction term 𝑊𝑖 ∗ 𝐷𝑖  reflects wealth associated 
with individuals in different demographic groups. For example, it shows how wealth is 
associated with individuals who have chronic conditions compared to those who do not 
have chronic conditions. 𝛽1 and 𝛽2 are the coefficients of interest, indicating the 
associations between wealth and TCM use within different groups.  
 
4. Results 
Description of the Sample 
 Table 1, Column 1 shows the distribution of age, gender, hukou, education, chronic 
conditions, household wealth, and household income among the study population. From 
the 19,282 respondents aged 45-plus years in the whole sample, 9424 (48.9%) were males 
and 9858 (51.1%) were females. The overall main age of was 60.29 years (SD 10.16). The 
majority of the respondents hold Agricultural hukou (77.0%) and only 813 (4.8%) of the 
population achieved a college degree. Among the respondents, 13,387(69.4%) had chronic 
conditions, which reflects the skewed distribution of chronic diseases in older populations.  
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4.1 Objective 1: TCM Use Patterns 
 Table 1, Columns 2 and 3 provide the summary of the characteristics of Non-TCM 
users and TCM users. Among the 19,282 valid participants of the survey in 2015, 5,534 
(28.7%) had used TCM. The TCM-use group had a mean age of 61.4, which is slightly older 
than the group who does not use TCM. Also, 56.1% of the TCM users were reported to be 
female. Both of the results align with the previous findings of studies in China and other 
developing countries.6, 36 In addition, TCM users were less educated than those who did not 
use TCM. While these differences are not very large, the differences are significant because 
of the large sample size. TCM use is commonly reported among respondents, especially 
among population with chronic conditions. As shown in Table 1, 89.2% of the population 
who used TCM had chronic conditions, compared to the 61.4% in the population who did 
not use TCM. In terms of our main variable of interest, the raw results show that the mean 
wealth score for TCM users is lower than that of the Non-TCM users.  
 TCM utilization rates in lieu of CM in the sample population are reported in the first 
row of Table 2. In the sample population, 501 (2.6%) used TCM without any CM treatment, 
while 9,169 (47.6%) used CM without any TCM treatment. Nearly 91% of the population 
who used TCM also used CM, which indicates the complementarity theory mentioned in the 
previous section that there might be a rising preference for using combined treatment to 
enhance clinical improvement in the Chinese community as economy grows.  
TCM utilization rates across various chronic conditions have similar trends in 
comparison with that of the sample population, which are both reported in Table 2. No 
notable differences were found across various chronic conditions. Among all fourteen 
chronic illnesses recorded, only people with arthritis (2.7%) or liver (2.7%) were found to 
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have a slightly higher frequency of TCM use than the sample population (2.6%) if we 
exclude those who use the combined treatment with both TCM and CM included. However, 
people with chronic conditions were more likely to use combined treatment. Memory 
(51.4%) and stroke (52.2%) have the highest utilization rates of combined treatment, 
compared with the sample population (26.1%). 
 In summary, there are naturally differences in the socioeconomic characteristics of 
the various medication use groups. In particular, older age, female, lower education level, 
and chronic medical conditions are associated with higher use of TCM.  
  
4.2 Objective 2: Wealth & TCM Use 
 Before presenting the regression estimates, we presented the unconditional 
correlations between wealth (& income) and the relative demand for TCM and CM. As 
shown in Table 3, people who only use TCM have a higher mean wealth score than any 
other groups. This may be partially caused by its relatively small sample size with only 501 
people included in this group. Contrary to the complementarity theory, both the wealth 
score and quantiles suggest that the group who use the most combined treatment are not 
the wealthiest population.  
To better examine how TCM use varies with wealth, we graphically examined the 
relationship between wealth and TCM use (including people who use combined treatment) 
in Graph 1. This graph shows the non-parametric relationship between wealth and TCM 
use estimated using local polynomial regression. The curve presents an inverted-u shaped 
relationship: TCM use initially increases with wealth, but then begins to decrease. This 
pattern could suggest that TCM is a low-cost substitute of CM. As wealth increases for very 
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poor people, they are able to afford medical services and have a preference for TCM 
because its relatively lower cost than CM, but as people become much wealthier, the 
demand for TCM starts to decline since now they can afford CM. However, these trends are 
only raw estimates without adjusting for covariates. 
 Regressions estimating the relationship between wealth and TCM use while 
adjusting for observable confounding factors are shown in Table 4. This table reports on 
two sets of stepwise OLS models to illustrate how the correlations between wealth and 
TCM vary as we control for different confounding variables. Model 1 to Model 3 used 
continuous wealth index as the major independent variable, whereas Model 4 to Model 6 
used wealth quantiles to evaluate the associations between wealth and TCM use. Model 1 
captures a negative relationship between household wealth and TCM use as we control for 
CM use. As we include the set of demographic variables and chronic diseases in Model 2, 
the regression result turned to be statistically insignificant. However, when we apply the 
full model which adds in the province fixed-effects and incorporate all control variables 
mentioned above, the results are statistically significant and show that wealth is positively 
related to TCM use. People who are wealthier are more likely to consume TCM, which is not 
expected as in the graph of raw estimates. The estimates of wealth quantiles tell a similar 
story but provide more details on the correlations between wealth and TCM use. As shown 
in Model 4 to Model 6, most of the positive relationship is due to the difference between the 
first quantile and the others. No significant differences were found from the 2nd quantile to 




4.3 Objective 3: Heterogeneity 
 Heterogeneity in the association between wealth and TCM use across different study 
groups is presented in Table 5. Looking at the results from the heterogeneous models, we 
found that there is a heterogeneity between young and older population in the association 
between wealth and TCM (Model 1). The point estimates are statistically significant at the 
1% level and indicate a stronger association between wealth and TCM in older population. 
For the elderly, the TCM use increases more than it does in younger population with 
increased wealth. One possible explanation for this finding is that older population is more 
subject to less income sources, combined with the fact that the elderly are more 
comfortable using TCM, leading to a larger role of wealth in TCM utilization. Results of 
Model 2 are not statistically significant. Therefore, no heterogeneity in associations 
between wealth and TCM is found across people with different education levels. As shown 
in Table 5, results from Model 3 are also statistically insignificant. It is surprising since 
wealth is expected to have a stronger association with TCM in population with chronic 
conditions as we found that people with chronic conditions are more likely to use TCM as 
part of the combined treatment. 
 
5. Discussion 
 The primary goal of this paper is to describe the use patterns of Traditional Chinese 
Medicine and Conventional Medicine and to examine the association between wealth and 
the relative demand for TCM and CM. We have several major findings. 
First, our study found that 28.7% of X to X year-olds in China use TCM. This is 
similar to what has been reported in previous studies.6, 36, 37 However, as one of the first to 
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investigate the relative use of TCM and CM, we found that only 2.6% of the population used 
TCM without using any CM and nearly 91% of the population who used TCM used the 
combined treatment with both TCM and CM included. This also aligns with a hospital study 
that found that most patients used the combination therapy.29 While developing countries 
are more expected to use TM as low-cost substitute because people have less access to 
affordable health care services, our results and previous findings in China suggest that 
there is an increasing preference for people to choose combined treatment given the 
economic and health system development in recent China. 
 Second, the role of chronic conditions in TCM use was also found to be notable. 
Relative to the sample population as a whole, people with chronic conditions have a much 
higher TCM utilization rate (89.2%). This clear link between chronic conditions and TCM 
use in our sample is comparable to other reports. Although our study was not designed to 
analyze causality between these two, it seems that chronic conditions bring about more 
TCM use and our findings somewhat confirm the popularity of TCM in the prevention and 
treatment of chronic disease in China. 
  Third, to the best of our knowledge, this study is the first to evaluate the association 
between wealth and TCM use in China. Notable differences were found between 
unconditional and conditional correlations. After we controlled for all confounding 
variables including CM use, demographic variables, and area fixed effects, wealth was 
positively associated with TCM use, despite the fact that TCM is commonly perceived as a 
low-cost substitute for CM. As wealthier people use more TCM than do their poorer 
counterparts when seeking medical treatments, TCM is perceived as a normal good. This 
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also implies the possibility that TCM is demanded as a complement for CM as people take a 
more proactive approach to supplementing CM with additional/alternative treatments.  
In the end, we found that there was a stronger association between wealth and TCM 
use in older populations, while no heterogeneity existed in the association between wealth 
and TCM use across individuals with different chronic conditions and education levels. One 
possible implication for this finding is that older population are more comfortable using 
TCM, leading to a larger role of wealth in TCM utilization. 
 Our study has a major strength and several limitations. The strength of this study is 
that we used a large and diverse national sample, which covered 19,282 participants from 
29 provinces but the findings should be considered with certain limitations in mind. First, 
since all health information and types of medication use (TCM & CM) were self-reported, 
the prevalence might be underestimated. Second, a limitation of our estimation strategy is 
that we only examined the correlations instead of the causation between TCM use and 
wealth. This is a secondary data analysis study that evaluated the association between 
wealth and TCM use but was unable to infer the causal effects of wealth on TCM use. We 
cannot employ methods that estimate causal effects such as instrumental variables due to 
the lack of instruments for wealth and TCM use. While we have controlled for different set 
of confounding factors, it is still possible that there are other omitted variables such as 
health status that will affect both wealth and TCM use.  
 This study adds important insights on the nature of demand for TCM and the role of 
wealth in TCM use, which may help policymakers design future health policies including 
health resources allocation and financing policies for health services. In response to the 
population aging and enlarged disease burden, the Chinese government has actively 
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promoted TCM development, integration, and supervision in recent years.4,6 Many 
researchers have focused on the ongoing efforts and challenges in TCM promotion, yet no 
one has ever investigated needs from the patient side. Our findings show that TCM, like CM, 
is commonly used by the Chinese population for illnesses, which highlights an important 
role of TCM in the Chinese population, especially for elderly with chronic conditions.  
 More importantly, the positive correlations we found between wealth and TCM use 
suggest the need for policymakers to revisit the strengths of and demand for TCM. If TCM is 
a normal good and is demanded as a complement for CM, it is important for the Chinese 
government to reallocate the scarce resources to best match people’s needs. Our findings 
also offer Chinese policymakers insights on the design of financing policies and 
reimbursement mechanisms for TCM and CM as we explored the heterogeneity across 
different groups.  
In summary, as the boundaries between TCM and CM are now quite permeable in 
China, more work is needed to identify the most cost-effective approach to integrating TCM 
into the mainstream health care system, providing safe, affordable and high-quality 
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